Inhibition of Collagen XVI Expression Reduces Glioma Cell Invasiveness by Bauer, Richard et al.
217
Original Paper
Cell Physiol Biochem 2011;27:217-226 Accepted: March 01, 2011Cellular Physiology
and Biochemistry
Copyright © 2011 S. Karger AG, Basel
Fax +41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
© 2011 S. Karger AG, Basel
1015-8987/11/0274-0217$38.00/0
Accessible online at:
www.karger.com/cpb
Inhibition of Collagen XVI Expression Reduces
Glioma Cell Invasiveness
Richard Bauer2,6*, Sabine Ratzinger3,6*, Lynn Wales1,6, Anja
Bosserhoff4, Volker Senner5, Joachim Grifka1 and Susanne
Grässel1,6
1Dept. of Orthopaedics, University Hospital Regensburg, 2Dept. of Maxillofacial Surgery, University Hos-
pital Regensburg, 3Dept. of Otorhinolaryngology, University Hospital Regensburg, 4Dept. of Molecular
Pathology, University Hospital Regensburg, 5Inst. of Neuropathology, University Hospital Münster, 6Cen-
tre for Biomedical Technology, BioPark 1, Regensburg, *Both authors contributed equally
Susanne Grässel, Ph.D.
Department of Orthopaedic Surgery, University Hospital Regensburg
ZMB / BioPark 1, Josef-Engert-Str. 9, 93053 Regensburg (Germany)
Tel. +49-941-943-5065, Fax +49-941-943-5066
E-Mail susanne.graessel@klinik.uni-regensburg.de
Key Words
Collagen XVI • Glioblastoma • Invasion • Protocadherin
• Integrin • Kindlin • Activation
Abstract
Glioblastomas are characterized by an intense local
invasiveness that limits surgical resection. One
mechanism by which glioma cells enforce their mi-
gration into brain tissue is reorganization of tumour
associated extracellular matrix (ECM). Collagen XVI
is a minor component of connective tissues. However,
in glioblastoma tissue it is dramatically upregulated
compared to the ECM of normal cortex. The aim of
this study is to delineate tumour cell invasion and
underlying mechanisms involving collagen XVI by
using a siRNA mediated collagen XVI knockdown
model in U87MG human glioblastoma cells. Knock-
down of collagen XVI resulted in decreased invasive-
ness in Boyden chamber assays, and in a reduction
of focal adhesion contact numbers per cell. Gene
expression was upregulated for protocadherin 18 and
downregulated for kindlin-1 and -2. Proliferation was
not affected while flow cytometric analysis demon-
strated reduced E1-integrin activation in collagen XVI
knockdown cells. We suggest that in glioblastoma tis-
sue collagen XVI may impair the cell-cell interaction
in favour of enhancement of invasion. The modifica-
tion of the E1-integrin activation pattern through col-
lagen XVI might be a molecular mechanism to further
augment the invasive phenotype of glioma cells. Elu-
cidating the underlying mechanisms of glioma cell
invasion promoted by collagen XVI may provide novel
cancer therapeutic approaches in neurooncology.
Introduction
Collagen XVI is a member of the fibril associated
collagens with interrupted triple helices (FACIT) colla-
gens and constitutes a minor component of the ECM of
skin, cartilage, brain and intestine. It is integrated into
distinct fibrillar aggregates such as fibrillin-1 containing
microfibrils in skin and D-banded cartilage fibrils [1, 2].
The presence of collagen XVI in the dermal epidermal
junction (DEJ) zone of the papillary dermis indicates an
active role in anchoring microfibrils to basement mem-
branes. By interconnecting ECM proteins to cells, colla-
gen XVI is likely to be able to move these proteins and
hence affects ECM networks, ensuring mechanical an-
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chorage of the cell and outside-inside signal transduc-
tion. Cell-matrix interactions are mostly mediated via
integrins which connect the ECM with the cytoskeleton
and enable ECM-components to induce cellular reactions
like cell adhesion, migration or gene activation [3]. Colla-
gen XVI interacts with integrins D1E1 and D2E1, how-
ever with higher affinity to D1E1 [4]. D1E1 and D2E1
integrins are expressed on glioma cell surfaces and con-
tribute to cell adhesion and migration [5, 6], hence these
integrins are likely to be an important link in terms of
interaction of cells with the ECM via collagen XVI. A
strong expression of collagen XVI was detected in murine
dorsal root ganglia during embryogenesis as well as dur-
ing regeneration after nerve injury [7]. This may indicate
that both maturation and regeneration of nerve cells re-
quire an interaction between neurons and the extracellu-
lar matrix (ECM), in which the specific role of collagen
XVI is not known to date.
Glioblastomas or gliomas are a relatively common
form of primary central nervous system (CNS) tumours
occurring in adults, and glioblastoma multiforme is the
most devastating type of glioma. Despite dramatic im-
provements in neuroimaging and neurosurgical techniques,
the prognosis in patients with gliomas has not improved
significantly during the past 40 years [8-10]. We demon-
strated a strong upregulation of collagen XVI in glioblas-
toma tissue, which is characterized by aggressive tumour
cell invasion into its surrounding tissue. Using glioma cell
lines as model system we observed that collagen XVI
ameliorates adhesion of these cells to matrix with the
glioma cell line U87MG showing strongest adhesion on
collagen XVI among all tested glioma cell lines [11].
Two other members of the FACIT collagens are
described to be involved in tumorigenesis and tumour cell
invasion, collagens XIX and XV. Both collagens are mainly
localized in basement membranes of normal tissues. Dur-
ing the development of ductal and lobular carcinomas of
the breast basement membranes become fragmented and
even lost in the progression of malignancy. In the very
beginning of tumour cell invasion, some extracellular pro-
teins, like FACIT collagens may act as attractants for
tumour cells. Notably, collagen XIX and XV disappear
from the basement membrane zone early in the develop-
ment of the invasive carcinomas possibly inducing re-
modelling of the ECM which promotes tumour cell infil-
tration [12]. Members of the FACIT collagens may act
as bridging proteins between collagen fibrils and other
components of the ECM and thus contribute to tissue
organization and stability. One may suggest that tumour
cells utilize these matrix components to identify and to
adhere to basement membranes. They seem to repre-
sent the first contact to tumour cells and facilitate their
adhesion. The loss of FACIT collagens during progres-
sion of the disease may indicate that these proteins, rep-
resenting the initial adhesion substrate are subsequently
digested by invading tumour cells to enable rearrange-
ment of the surrounding matrix.
Here, we hypothesize that collagen XVI affects
migration and invasion capacity of glioma cells. We show
that collagen XVI gene silencing in the glioblastoma cell
line U87MG affects genes involved in cell-cell and cell-
matrix associated signal transduction pathways. Reduc-
tion of collagen XVI causes a profound decrease of fo-
cal adhesion contacts which are crucial for cell-matrix
interaction and transduction of outside-inside signalling.
Collagen XVI gene silencing affects invasive behaviour
of the U87MG cells, implying collagen XVI to be an im-
portant player in tumorigenesis and metastasis of glio-
blastoma. There is strong evidence for collagen XVI to
play a crucial role in interaction between cells and the
ECM via molecules of the plasma membrane and the
cytoskeleton.
Materials  and Methods
Cell Culture
The human glioblastoma cell line U87MG (ATCC: HTB-
14) was cultured in high glucose Dulbecco’s modified Eagle’s
medium (DMEM, Invitrogen, Paisley, UK) supplemented with
10% fetal calf serum (Sigma, St. Louis, USA) and 1% penicillin/
streptomycin (PAA, Coelbe, Germany) at 37°C in 5% CO2.
Transfection
Transfection of the U87MG cells was performed by
electroporation using the Amaxa Nucleofector system (Lonza,
Allendale, USA) with a Cell Line Nucleofector Kit T (VCA-
1002, Lonza, Allendale, USA) according to the manufacturer’s
protocol. 5x105 cells per reaction were incubated with 80 pmol
of siRNA (8pmol / μl) and 100 μl Nucleofector solution and run
on program X-01. The cells were transfected with two collagen
XVI-specific siRNAs: siRNA1 (5’-uga gcu cau uga gau caa u
dTdT-3’) and siRNA2 (5’-gga cuc aaa uug gaa cac a dTdT-3’)
and the corresponding sequences as double strand; as well as
scrambled siRNA (control) as described elsewhere [11]. All
siRNAs were purchased from Qiagen, Hilden, Germany.
Transfection was completed by incubating the cells for 48 h at
37°C in 5% CO2 before they were subjected to RNA and protein
isolation or functional assays.
RNA isolation and quantitative real-time PCR
RNA was isolated with Qiagen RNeasy Mini Kit accord-
ing to the manufacturer’s protocol. DNA contamination was
eliminated by DNase I enzyme (DNAfree, Ambion/Applied
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Biosystems, Austin, USA) and up to 3 μg RNA was converted
into cDNA with 500 ng/ml Oligo dT primers, 10 mM dNTPs, 0.1
M DTT and 200 units of SuperScript II enzyme (all Invitrogen,
Paisley, UK) using the AffinityScript QPCR cDNA Synthesis
Kit (Stratagene, Waldbronn, Germany) according to manufac-
turer‘s protocol. Quantitative real-time PCR (qPCR) was per-
formed with SYBR Green Dye I on the MX3005 (Stratagene,
Waldbronn, Germany) in triplicates, using cDNA concentra-
tions that referred to 25 ng of RNA per reaction. For quantifica-
tion, plasmid standard curves for COL16A1 were generated in
copy numbers ranging from 102 to 107 to calculate COL16A1
cDNA copy numbers in samples and to determine knockdown
efficiency. For PCDH18, KINDLIN-1 and KINDLIN-2, relative
quantification was evaluated by the ''Ct method using
GAPDH as reference gene for normalization of gene of interest
and, the scrambled RNA transfected cells were used as calibra-
tor. The mean relative quantification (RQ) values and absolute
copy numbers were calculated using the detection software
MxPro v 4.1 (Stratagene, Waldbronn, Germany). Primers for
COL16A1 [13], PCDH18 (F: 5’-agc atc tgc agc ttt tcc at-3’; R:
5’-agg gaa ttt tcc cca aca tc-3’), KINDLIN-1 (F: 5’-cca ccg gga
ttc cag tga caa c-3’; R: 5’-ccg ccg gtc aat ttg tgg acc-3’),
KINDLIN-2, (F: 5’-gca aga cca tgg cgg aca gtt c-3’; R: 5’-gat
ggg cct cca aga ttc tcg c-3’) and GAPDH (F: 5’- ctg act tca aca
gcg aca cc-3’; R: 5’- ccc tgt tgc tgt agc caa at-3’) were designed
with Primer3 software and synthesized from MWG-Biotech,
Ebersberg, Germany.
Quantitative gene expression for MMP-genes was done
using Brilliant II Fast qPCR Master Mix from Stratagene (Agilent
Technologies, Santa Clara, USA) with Taqman upl probes
(Roche). Primers for E-ACTIN: 5’-att ggc aat gag cgg ttc-3’ and
5’-tga agg tag ttt cgt gga tgc-3’; .MMP-2: 5’-ttg atg acg atg agc
tat gga-3’ and 5’-act tgc agt act ccc cat cg-3’; .MT1-MMP: 5’-
gag cct tgg act gtc agg aa-3’ and 5’-ggg gtc act gga atg ctc -3’.
E-actin mRNA was used for normalisation.
Protein precipitation and western blotting
Cell pellets were lysed in NP40-buffer containing 1% NP40
(Nonidet®P40 substitute, Fluka, Munich, Germany), 150 mM
NaCl, 50 mM Tris-HCl, pH 8.0 (AppliChem, Darmstadt, Ger-
many), and protease inhibitor cocktail (Complete Mini, 1 tablet
per 10 ml buffer, Roche, Mannheim, Germany) for 30 min on ice
with intermittent shaking. Samples were harvested 2 days or 4
days post transfection as indicated.
Total protein concentration was determined using BCA
protein quantification (Pierce, Rockford, USA) according to
the manufacturer’s protocol. For analysis of collagen XVI knock-
down 20 μg and for analysis of PCDH18 expression 50 μg of
protein was added to 0.1 M Tris/HCl (pH 6.8, AppliChem,
Darmstadt, Germany) sample buffer containing 2% SDS (Roth,
Karlsruhe, Germany), 20% glycerine (AppliChem, Darmstadt,
Germany), 5% E-mercaptoethanol (Sigma, St. Louis, USA) and
0.01% bromphenolblue (Sigma, St. Louis, USA) and, subjected
to 4.5% to 15% gradient SDS-PAGE before being transferred to
a nitrocellulose membrane (Schleicher & Schuell, Dassel, Ger-
many). 2ml of cell supernatant was collected and concentrated
using Amicon® Ultra centrifugal filters (Millipore). Protein
quantification was performed as described above. For western
blot analysis 30μg of protein was loaded onto the gel. For
collagen XVI western blot a SemiDry-Blotter (MBT, Micro-Bio-
Tec Brand, Gießen, Germany) was used for 1 h at 0,48 mA/cm2
and for PCDH18 western blot a Tank blot system (customized
construction University Hospital Münster) was used for 4 h at
80 mA. As a control for the PCDH18 antibody 20 μg of cell
lysate from mouse lung was included. Blocking was performed
for 1 h at RT with 5% dry milk (Roth, Karlsruhe, Germany) in T-
PBS (0.05% Tween-20 in 1x PBS). The membrane was incu-
bated with the primary antibody (antibodies: gp-anti-Col XVI,
protein A purified, dilution, 1:1000 [14] or rabbit-anti-PCDH18
(dilution, 1:250; Sigma-Aldrich Inc., St. Louis, USA), polyclonal
anti-Kindlin-1 (rabbit IgG: 5 μg/ml, Abcam, Cambridge, UK),
polyclonal anti-Kindlin-2 (rabbit IgG: 3 μg/ml, Sigma-Aldrich)
and rabbit- anti- E-actin (dilution, 1:5000; Abcam) over night at
4°C. After washing off excess antibody solution, the membrane
was incubated with horseradish peroxidase conjugated sec-
ondary antibody (goat-anti-guinea pig peroxidase conjugated;
dilution, 1:30.000; Sigma-Aldrich Inc., St. Louis, USA) for col-
lagen XVI antibody or donkey-anti-rabbit IgG (Dilution, 1:5000;
Jackson Immuno Laboratories Inc., West Grove, USA) for PCDH
18, Kindlin-1, Kindlin-2  and E-actin antibodies for 1 h at RT.
Immunoreactive bands were detected with chemiluminescence
(ECL Western Blotting Substrates, Pierce, Rockford, USA).
Proliferation assay
96-well plates (MaxiSorb, BD Falcon, Franklin Lakes, USA)
were coated separately with poly-L-lysin (5 μg/ml; Sigma, St.
Louis, USA), collagen I (10 μg/ml; Sigma, St. Louis, USA),
recombinant collagen XVI [14] (10 μg/ml and 30 μg/ml) over
night at 4°C. This was followed by two washing steps with
PBS and a coating with 1 % BSA solution (w/v) (Biomol, Ham-
burg, Germany) for 2 h at RT to block unspecific binding sites.
The plates were washed two times with PBS and stored at 4°C
until usage. Transfected U87MG cells were trypsinized, seeded
into the coated 96-well-plates at a density of 7.500 cells/well
and cultivated over night at 37°C and 5% CO2. EZ4U prolifera-
tion assay (Biomedica, Vienna, Austria), based on conversion
of tetrazolium salt to formazan by active succinatdehdrogenase
from living cells, was performed according to the manufactur-
ers protocol for 2 h, 4 h and 6 h. Absorption was determined at
450 nm and a reference wavelength of 600 nm in a microplate
reader (Tecan, Maennedorf, Switzerland). The assay was per-
formed in triplicates and as 3 independent experiments.
Cell morphology and focal adhesion contacts
For examination of the cell morphology, transfected cells
were grown on uncoated chamber slides (BD Falcon, Franklin
Lakes, USA, 40.000 cells/chamber) in normal growth medium.
After incubation over night the cells were fixed with 4% PFA in
PBST (0.1% Tween) for 5 min before washing in PBS, adding
0.1 M NH4Cl (AppliChem, Darmstadt, Germany) for 10 min and
washing again. The cells were then blocked over night at 4°C
with 1% NGS (normal goat serum, Dako, Glostrup, Denmark) in
PBS. For visualization of focal adhesion contacts, the cells
were incubated with the primary antibody mouse-anti-human
vinculin (Sigma, St. Louis, USA, 1:500 in 1% NGS in PBS) for
1 h at 37°C, followed by the secondary Alexa 488 conjugated
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goat-anti-mouse antibody (Invitrogen, Paisley, UK, 1:500 in
1% NGS in PBS) for another hour at 37°C. The cell nuclei were
labelled with 4',6-diamidino-2-phenylindole (DAPI; Invitrogen,
Paisley, UK, 300 nM) for 10 min. Finally the slides were mounted
in fluorescent mounting medium (Dako, Glostrup, Denmark)
and evaluated with laser scanning microscopy (C1 confocal
microscope, Nikon) and Nikon C4 camera and software.
Evaluation of focal adhesion contact number (FACs)
Determination of FACs numbers in U87MG cells was car-
ried out by counting the number of FACs represented by posi-
tive vinculin fluorescence staining in five randomly chosen
fields of view and then determining the average number of
FACs per cell.
Cell invasion assay
Differences in the invasiveness of collagen XVI-silenced
cells to control cells were investigated by using a Boyden
Chamber Invasion assay (BD Biosciences, San Jose, USA).
The system is based on two medium-filled compartments with
a well diameter according to a 24 well plate, separated by an 8
μm microporous membrane coated with Matrigel, diluted 1:3
with serum-free medium (BD Biosciences, San Jose, USA). The
lower compartment contains fibroblast conditioned culture
supernatant (from 80% confluent fibroblasts cultured in DMEM,
10% FCS, 1% Pen/Strep) in order to stimulate cell migration.
Cells (150.000/ml) were placed in the upper compartment and
were allowed to migrate through the pores of the membrane
into the lower compartment. After an incubation time of 4 h, the
membrane separating the two compartments was fixed
(Hemacolor solution 1, #111957, Merck, Darmstadt, Germany)
and stained to visualize cytoplasm and nuclei (Hemacolor so-
lution 2, #111956, Hemacolor solution 3, # 111955, Merck,
Darmstadt, Germany). The number of cells migrated to the lower
side of the membrane was determined with light microscopy
choosing five independent fields of view for each independent
experiment (N = 4).
Adhesion Assay
U87MG cells were seeded at a density of 7.500 cells/well
into a 96-well plate without additional coating. Cells were al-
lowed to adhere for 4 h and 6 h at 37 °C at 5 % CO2. Subse-
quently, plates were washed with PBS in order to remove non-
adhered cells. Adhered cells were fixed with 1 % (v/v) glutaral-
dehyde solution (Merck, Darmstadt, Germany) for 30 min. Glu-
taraldehyde was removed and cells were repeatedly washed
with PBS. Fixed cells were stained with 0.02 % (w/v) crystal-
violet solution (Sigma, Munic, Germany) for 15 min at rt and
washed with tap water. Bound crystal violet was removed by
incubation for 3 h on a horizontal shaker at 100 rpm with 70 %
(v/v) ethanol (Roth, Karlsruhe, Germany). Crystal violet ad-
sorption was measured at 595 nm and each sample was ana-
lysed in triplicates from three independent experiments.
FACS analysis for E1-integrin activation
Flow cytometry was performed using a FACSCanto II
flow cytometer (BD Biosciences, Heidelberg, Germany)
equipped with 488 nm blue and 633 nm red diode lasers. Cells
were fixed for 15 min on ice in methanol:acetone (3:1), washed
twice in PBS (+ 2% BSA). First antibodies were incubated for
1.5 h at 37 °C (Monoclonal anti- integrin E1 (C-terminus, mouse
IgG: 10 μg/ml, Millipore MAB2259Z, Monoclonal anti- integrin
E1D (N-terminus mouse IgG: 10 μg/ml, Millipore MAB1900).
After two washing steps in PBS (+ 2% BSA) cells were treated
for 1 h at room temperature with secondary antibodies linked
to AlexaFluor 488 (Invitrogen, Darmstadt, Germany). Data evalu-
ation was performed with FACSdiva software (BD Biosciences,
San Jose, USA). The SFI value was calculated by dividing the
geometric mean values of the fluorescence units of scrambled,
si1 and si2 samples by the correspondent value of the isotype
control, in each channel.
Statistical analysis
Results are shown in average values ±standard error of
mean. For each siRNA at least 5 knockdown experiments were
analyzed in triplicates. Significances were determined with as-
sistance of GraphPadPrism v.5 by one-way Anova analysis of
variance and as posthoc test with unpaired student’s t-test.
Results
Knockdown efficiency
Knockdown efficiency of siRNA1 and siRNA2 was
evaluated 48 hours (2 days) after transfection in com-
parison to scrambled (scr) RNA by determination of gene
and protein expression level of collagen XVI.
The knockdown effect was evaluated on protein level
with western blotting 2 days post transfection. A pro-
found reduction of the full-length collagen XVI chain band
for both siRNAs (1+2) was observed in cell lysates (Fig.
1A) and cell supernatant (Fig. 1B) compared to the
scrRNA samples and the untreated U87MG cells.
Gene expression level of COL16A1 was determined
in absolute cDNA copy numbers using a plasmid stand-
ard curve. It is displayed separately for siRNA1 and
siRNA2 in % of controls which are U87MG cells
transfected with scrambled RNA (Fig. 1C). GAPDH
gene expression served as endogenous control for siRNA
specificity and remained unaffected (data not shown). In
general, a COL16A1 transcript reduction of ~60 % was
obtained in comparison to the control cells (scr RNA).
Cell morphology and focal adhesion contacts
Morphology of transfected cells, both control and
collagen XVI-knockdown cells, was analyzed by fluo-
rescence microscopy. At that level of investigation no
morphological differences concerning cell size and shape
were detected between control cells and knockdown cells
(Fig. 2A). However, cellular distribution and in particular
numbers of focal adhesion contacts (FACs) represented
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by vinculin staining were affected in knockdown cells.
Evaluation of the number of FACs per cell by counting
the positive vinculin stained spots yielded a significant
decrease of 40-45% of FAC number per cell in case of
collagen XVI knockdown (Fig. 2B).
Proliferation properties
Analysis of cell proliferation assays revealed no
differences between collagen XVI-knockdown U87MG
cells and controls on various surface coatings (BSA and
PLL as controls, 10 μg and 30 μg of recombinant colla-
gen XVI)  during the time line of the assay (2, 4 and 6
hours), (data not shown).
Fig. 1. Analysis of COL16A1 knockdown efficiency. (A) The knockdown was translated to the protein level as shown for the
full-length collagen XVI chain in cell lysates in comparison to the scr control and untreated U87MG cells. E-actin. protein
expression is unaffected which indicates a specific knockdown of collagen XVI. N = 4 (B) Collagen XVI inhibited cells secreted
less collagen XVI into the supernatant in comparison to scr controls. Ponceau Red stained blot membrane served as loading
control. N=3 (C) Knockdown efficiency of COL16A1 was analyzed with qRT-PCR and shows an average of 60% lower COL16A1
gene expression in transfected U87MG cells (si1 and si2) compared to control cells transfected with scrambled RNA (scr).
N = 19, si1= siRNA 1, si2 = siRNA 2, scr = scrambled RNA = controls.
Fig. 2. Cell morphology and number of focal adhesion contacts. (A) U87MG cells were stained using vinculin antibodies to
visualize cell morphology and focal adhesion contacts. Representative images (magnification 200x and 400x) demonstrate that in
collagen XVI-knockdown cells FACs were found more concentrated in the cellular periphery while in control cells FACs (white
arrows) appeared to be more evenly distributed. N = 4. (B) The number of FACs per cell is significantly decreased in collagen XVI
knockdown cells. The evaluation of the number of focal adhesion contacts yielded a significant decrease of 40-45% of FACs
per cell after inhibition of collagen XVI. A similar reduction of focal adhesion contacts was observed for both siRNAs. N = 4;
 * = p < 0.05.
Collagen XVI in Glioblastoma
A B
Cell invasion and adhesion potential
Collagen XVI-knockdown cells revealed a
 significantly reduced invasive potential in the Boyden
Chamber assay compared to control cells. Around
50% less U87MG cells migrated through the microporous
membrane coated with Matrigel after COL16A1
gene expression was suppressed (Fig. 3A). Here, si1RNA
mediated collagen XVI knock down reduced
invasion more effectively compared to si2RNA.
Adhesion of collagen XVI-knockdown cells to cell
culture plastic revealed no differences compared to
control cells after 4 hours and 6 hours of incubation
(Fig. 3B). Therefore, decreased invasion rate is not a
Cell Physiol Biochem 2011;27:217-226
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consequence of increased cellular adhesion.
Analysis of downstream gene and protein expres-
sion
Quantitative real-time RT-PCR was carried out
for analysis of gene expression of protocadherin
18 (PCDH18), kindlin-1 and kindlin-2. Relative gene
expression analysis with the ''Ct method demonstrated
a profound upregulation of PCDH18. In addition to
this, kindlin-1 and kindlin-2 mRNA levels were
significantly reduced in collagen XVI-silenced cells
(Fig. 4A). Analysis of protocadherin 18 protein expres-
sion in cell lysates revealed one clear band of the
protein at about 126 kDa. Samples which were lysed 2
days post transfection generated a stronger signal
for PCDH18 in collagen XVI-knockdown U87MG cell
lysates compared to the scr controls (Fig. 4B).
Westernblot analysis of Kindlin-1 (Fig. 4C) and
Kindlin-2 (Fig. 4D) protein expression using cell
lysates have shown that both molecules were inhibited
on protein level in addition to mRNA level.
Analysis of matrix degrading enzymes MMP-2
and MT1-MMP
As MMP-2 and MT1-MMP are important proteases
for cell metastasis and thus migration of cells we have
analysed mRNA level of both enzymes (Fig. 5). Knock-
down of collagen XVI did not affect gene expression
Fig. 3. Invasive potential of collagen XVI inhibited cells. (A) Downregulation of collagen XVI expression resulted in a reduced
invasion of U87MG cells in a Boyden Chamber assay compared to scr-control cells. The number of cells migrated to the lower
compartment after 4 hours was significantly decreased in knockdown cells compared to the control. N = 4; * = p< 0.05;
** = p<0.01. (B, C) Adhesion capacity after 4 hours and 6 hours was not influenced by reduced collagen XVI expression. N = 6.
Fig. 4. Downstream gene expression
analysis. (A) Gene expression of
PCDH18, kindlin-1 and kindlin-2
was determined by qRT-PCR and
evaluated using the ''Ct method
with GAPDH as endogenous loading
control set to 0 and U87MG cells
transfected with scrambled RNA as
calibrator. PCDH18 gene expression
was profoundly upregulated whereas
gene expression of kindlin-1 and
kindlin-2 was clearly downregulated.
N = 6. ***= p< 0.001. Protein expres-
sion of PCDH 18 (B), Kindlin-1 (C) and
Kindlin-2 (D) was determined with
western blotting analysis of cell
lysates. E-Actin was used as internal
loading control. N=3. Control: cell
lysate from mouse lung.
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of MMP-2 (Fig. 5A) and MT1-MMP (Fig. 5B).
Analysis of E1-integrin activation status
Flow cytometric analysis of collagen XVI-knock-
down and control U87MG cells 96 hours post transfection
revealed a clear reduction of the signal count for
activated E1 (antibody integrin beta1D recognizes the
activated E1-integrin form only) compared to control
cells. Specific antibody binding signals to activated
E1-integrins were reduced of about 50% in collagen
XVI-knockdown cells for both siRNAs (Fig. 6A).
Notably, protein expression of total E1-integrin was mainly
unaltered (Fig. 6B).
Discussion
It is of great interest to unravel details of how a
cancerous cell of the CNS interacts with the surrounding
ECM. Here, the matrix bears a dual role as a physical
barrier and as anchoring point for tractional forces. De-
lineating mechanisms of cell-to-cell and cell-to-matrix in-
teractions is imperative in understanding the invasiveness
of tumour cells in order to develop new therapeutical strat-
egies in neurooncology. Thus, inhibition of collagen XVI
Fig. 5. Gene expression analysis for
MMP-2 and MT1-MMP. mRNA level
for MMP-2 (A) and MT1-MMP (B)
were analyzed with specific Taqman
probes for both enzymes. N=3.
Fig. 6. Flow cytometric analysis of E1-integrin expression and
activation status. FACS analysis was performed to determine
E1-integrin expression and activation on collagen XVI-knock-
down U87MG cells and scr controls 96 hours post transfection.
(A) The antibody integrin beta1D (MAB2259Z) recognizes
activated E1-integrin only. Compared to controls E1-integrin
was about 50% less activated on collagen XVI-knockdown
cells. (B) The antibody integrin beta1 (MAB1900) binds to to-
tal E1-integrins (both activated and inactivated forms). There-
fore, the result demonstrates that total expression of E1-integrin
was not altered on collagen XVI-knockdown cells. black line:
Isotype control which is the secondary antibody without first
antibody. si1= siRNA 1, si2 = siRNA 2, scr = scrambled RNA.
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via RNAi in the tumour cell line U87MG provides a po-
tent tool to analyze the role of this collagen in tumour
development and metastasis. In a previous study this cell
line has revealed high levels of collagen XVI gene and
protein expression and also a strong interaction with
recombinant collagen XVI in adhesion and migration as-
says [11].
ECM in the central nervous system is composed of
molecules synthesized and secreted by neurons and glial
cells. Normal human brain is largely free of a well-de-
fined ECM [15], except for the perivascular space that
represents a frequent site for glioma cell invasion [16].
Glioblastomas are defined by an accumulation of several
large ECM-components, i.e. collagens I, IV, VI, and
fibronectin, laminin, versican, decorin, and tenascin-C [17,
18]. It has been demonstrated that increasing concentra-
tions of collagen I correlate positively with tumour inva-
siveness, but negatively with tumour growth. Functional
studies have shown that migrating glioma cells are able
to influence and alter their surrounding matrix by align-
ment, strain stiffening and breaking of specific compo-
nents [19]. In contrast to normal cortex, expression of
collagen XVI is highly upregulated in glioblastoma tissue
mainly pericellular and around cerebral vessels adjacent
to the basement membrane. Profound upregulation of
collagen XVI expression in glioblastomas suggests that
collagen XVI within the tumour-specific ECM is of cru-
cial importance for the development and/or establishment
of tumours. As there is evidence that collagen XVI is
involved in signal transduction and cell-matrix interaction
[4], it may be a prerequisite for ensuring tumour invasion
and metastasis. Major matrix components like fibrillar
collagens occur in high quantities compared to minor com-
ponents like FACIT-collagens. However, members of this
collagen family act as linker proteins between fibrillar
structures and extra-fibrillar matrix via other adapter
molecules like COMP or matrilins [2, 20] and thus are
crucial for formation and stability of large fibrillar net-
works.
In vitro studies have shown the importance of
fibronectin, laminin, collagen IV and other ECM proteins
in stimulating a migratory phenotype in glioblastoma cell
lines [21]. In this line, knockdown of collagen XVI in
U87MG cells did result in a reduced invasive potential.
Of note, overexpression of collagen XVI in PCI13, a rep-
resentative oral squamous cell carcinoma (OSCC) cell
line, strongly induced cellular invasiveness [22]. De-
creased invasiveness of collagen XVI-inhibited U87MG
cells is not due to increased matrix adhesion as this is not
changed during the time line (4-6 hours) of the invasion
assay. Glioma cell invasion is regarded to occur along
ECM protein-containing structures, such as along tracts
of myelinated fibres [23-25]. Collagen XVI seems to be
a preferred substrate for glioma cells and might serve as
a migratory tract in a rearranged matrix micro-
environment. Cellular migration involves initial protrusion
of the leading edge, formation of adhesive sites, contrac-
tion of the cell, and release of adhesive sites at the cell
rear [26]. Adhesive sites are variable in size and molecu-
lar composition. In focal adhesion contacts (FACs),
integrins, actin stress fibers, other structural proteins, and
signalling molecules accumulate to form a multi-protein
complex [27]. Immunofluorescence staining displays a
clear reduction in the number and alteration in distribu-
tion of FACs in collagen XVI-knockdown cells. Adhe-
sion of cells is a prerequisite for cellular migration and
invasion, including creation of space and the ability to
move into this space. The process of cell migration in-
volves dynamic interactions between the cell and its ECM.
The DE-integrin heterodimers are able to bind non-
covalently to structures of many ECM proteins and serve
as transmembrane linker. For collagen XVI high affinity
binding sites to D1E1- and D2E1- integrins have been
identified in the C-terminal region of the molecule [4].
The E1 chain appears to be a critical component, as it is
capable of hetero-dimerization with collagen XVI bind-
ing D-subunits. Of note, in PCI13 collagen XVI
overexpressing OSCC cells E1-integrin activity is induced
together with an increased D1-integrin expression [22].
Additionally, we demonstrated that myofibroblasts iso-
lated from inflamed colon regions of Crohns Disease
patients induced expression of collagen XVI together with
D1-integrin expression while D2-integrin was unaffected
[13].
Intracellularly, the E1-integrin subunit interacts with
kindlins in a multiprotein complex which is part of the
cytoskeleton [28]. Thereby contractile tension forces are
generated that induce morphological changes and cellu-
lar motility [16]. On the other hand, kindlins are able to
induce integrin-ECM interactions by activating integrins
and the subsequent generation and induction of the for-
mation of FACs. An Affimetrix cDNA microarray ap-
proach (human genome U133 Plus 2.0 Array performed
for two knockdown cDNAs and two non-interfering
cDNA samples of U87MG; data not shown) revealed a
significant down-regulation of kindlins among other genes
in collagen XVI-knockdown cells. Comparison of colla-
gen XVI-knockdown and control cells by quantitative PCR
confirmed this observation for kindlin-1 and kindlin-2.
These results are in line with a clearly decreased E1
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integrin activity but unchanged total expression of the E1-
integrin subunit on the cell surface in collagen XVI-knock-
down U87MG cells.
Of note, cell-matrix interactions are inverse regu-
lated to cell-cell interactions which are mediated via
cadherins among other cell adhesion molecules. Cadherins
are cell-cell contact molecules that mediate Ca2+-depend-
ent cell-cell adhesion and are localized in adherence-type
junctions. They can form bridges to the actin cytoskele-
ton and play an important role in the organization of tis-
sues. Protocadherin 18 (PCDH18), a member of the
delta-protocadherin family in brain [29, 30] belongs to
the cell adhesion molecule family which is frequently
downregulated in cancers [31], proved to be strongly
up-regulated in collagen XVI knockdown cells. Mem-
bers of the protocadherin family as PCDH8, -10, -17 and
-20 are suggested to functioning as tumour suppressor
genes as silencing in carcinomas induces cell prolifera-
tion and migration/ invasion of tumour cells. A recent
study demonstrated a tumour suppressor role of
PCDH10 with inhibition of the growth, migration, and in-
vasion of nasopharyngeal cancer cells upon over-
expression [32-34]. In line with this observation is
that in high-grade glioblastomas an upregulation of
N-cadherin correlates with a dramatic decrease in inva-
sive behaviour [35]. Here, we show that after inhibition
of collagen XVI expression protocadherin 18 upregulation
correlates with a significant decrease in invasive poten-
tial of U87MG cells.
Tumour cell growth and invasion in the CNS needs
complex interactions between malignant cells, glial cells,
neuronal cells and endothelial cells. It is discussed whether
an invasive cell utilizes constitutively pre-existing brain
ECM for migration, or if it is actively producing and se-
creting its own matrix for subsequent invasion [36]. The
enzymatic profile of tumour cells may also have an enor-
mous impact on the integrity of ECM components. Here,
we were unable to detect an impact of collagen XVI on
regulation of gene expression level of the two important
MMPs, MMP-2 and MT1-MMP, in tumour metastasis.
However, it has been demonstrated for several FACIT
collagens, that single isolated collagen domains can ex-
hibit anti-tumour activity [37]. As recombinant [14] and
authentic [38] collagen XVI might be proteolytically
cleaved into fragments with distinct molecular weights, it
should be the focus of follow up studies to investigate the
effect of tumour associated enzymes, i.e. MMPs, on the
cleavage of collagen XVI and the effect of singular do-
mains of collagen XVI on tumorigenesis.
Our results suggest that glioma cells in fact create
their own microenvironment by upregulating expression
and biosynthesis of specific macromolecules as collagen
XVI. We demonstrated that loss of collagen XVI alters
glioma cell invasion. Reduced invasiveness of collagen
XVI-knockdown U87MG cells might be correlated with
increased PCDH18 expression which ensures increased
cell-to-cell contact. Increased cell-to-cell interaction pre-
sumes reduced cell-matrix interaction as demonstrated
by reduced invasion. This observation is supported by
reduced kindlin-1/-2 gene and protein expression which
results in reduced integrin E1 activation without altera-
tion of total E1-integrin protein expression
Further functional studies on the invasive glioblas-
toma phenotype in order to characterize the link between
collagen XVI and downstream signalling molecules which
directly mediate cell-to -cell and cell- to- matrix interac-
tions are necessary to improve strategies of anti-invasive
cancer therapies.
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